These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3903562)

  • 1. Regulation of plasma cholesterol by compactin and mevinolin.
    Nutr Rev; 1985 Sep; 43(9):266-8. PubMed ID: 3903562
    [No Abstract]   [Full Text] [Related]  

  • 2. Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase.
    Endo A
    J Med Chem; 1985 Apr; 28(4):401-5. PubMed ID: 3981532
    [No Abstract]   [Full Text] [Related]  

  • 3. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
    Alberts AW; Chen J; Kuron G; Hunt V; Huff J; Hoffman C; Rothrock J; Lopez M; Joshua H; Harris E; Patchett A; Monaghan R; Currie S; Stapley E; Albers-Schonberg G; Hensens O; Hirshfield J; Hoogsteen K; Liesch J; Springer J
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3957-61. PubMed ID: 6933445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme A reductase.
    Tobert JA; Hitzenberger G; Kukovetz WR; Holmes IB; Jones KH
    Atherosclerosis; 1982 Jan; 41(1):61-5. PubMed ID: 6918220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks.
    Fears R; Richards DH; Ferres H
    Atherosclerosis; 1980 Apr; 35(4):439-49. PubMed ID: 7189661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.
    Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
    N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin.
    Chao Y; Chen JS; Hunt VM; Kuron GW; Karkas JD; Liou R; Alberts AW
    Eur J Clin Pharmacol; 1991; 40 Suppl 1():S11-4. PubMed ID: 2044637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical aspect of HMG CoA reductase inhibitors.
    Endo A; Hasumi K
    Adv Enzyme Regul; 1989; 28():53-64. PubMed ID: 2696346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mevinolin stimulates receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.
    Bilheimer DW; Grundy SM; Brown MS; Goldstein JL
    Trans Assoc Am Physicians; 1983; 96():1-9. PubMed ID: 6388097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercholesterolemia persisting after distal ileal bypass: response to mevinolin.
    Illingworth DR; Connor WE
    Ann Intern Med; 1984 Jun; 100(6):850-1. PubMed ID: 6562870
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of cholesterol synthesis by mevinolin stimulates low density lipoprotein receptor activity in human monocyte-derived macrophages.
    Traber MG; Kayden HJ
    Atherosclerosis; 1984 Jul; 52(1):1-11. PubMed ID: 6087838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors.
    Endo A
    Methods Enzymol; 1981; 72():684-9. PubMed ID: 7311861
    [No Abstract]   [Full Text] [Related]  

  • 13. Mevinolin, an inhibitor of cholesterol synthesis, induces mRNA for low density lipoprotein receptor in livers of hamsters and rabbits.
    Ma PT; Gil G; Südhof TC; Bilheimer DW; Goldstein JL; Brown MS
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8370-4. PubMed ID: 3464957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacologic therapy of arteriosclerosis. II. New directions].
    Santafé Oroz J; Segarra Domènech J
    Med Clin (Barc); 1985 Jan; 84(3):115-22. PubMed ID: 3919229
    [No Abstract]   [Full Text] [Related]  

  • 15. Lowering plasma cholesterol by raising ldl receptors. 1981.
    Brown MS; Goldstein JL
    Atheroscler Suppl; 2004 Oct; 5(3):57-9. PubMed ID: 15531276
    [No Abstract]   [Full Text] [Related]  

  • 16. Mevinolin: a highly specific inhibitor of microsomal 3-hydroxy-3-methylglutaryl-coenzyme A reductase of radish plants.
    Bach TJ; Lichtenthaler HK
    Z Naturforsch C Biosci; 1982; 37(1-2):46-50. PubMed ID: 6917646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compactin inhibits cholesterol synthesis in lymphocytes and intestinal mucosa from patients with familial hypercholesterolaemia.
    Betteridge DJ; Krone W; Reckless JP; Galton DJ
    Lancet; 1978 Dec 23-30; 2(8104-5):1342-3. PubMed ID: 82843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effect of six compactin-related compounds on cholesterol synthesis in five human cell types.
    Sviridov DD; Endo A; Pavlov MYu ; Repin VS; Smirnov VN
    Lipids; 1990 Nov; 25(11):685-90. PubMed ID: 2280672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time response of cholesterol synthesis inhibition by compactin-related compounds. In vitro quantitation of the "escape phenomenon".
    Sviridov DD; Endo A; Pavlov MY; Repin VS
    Lipids; 1993 Jun; 28(6):569-71. PubMed ID: 8355584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering plasma cholesterol by raising LDL receptors.
    Brown MS; Goldstein JL
    N Engl J Med; 1981 Aug; 305(9):515-7. PubMed ID: 6265781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.